Cite

HARVARD Citation

    Marques, F. et al. (2017). Experimental and Human Evidence for Lipocalin‐2 (Neutrophil Gelatinase‐Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and Heart Failure. Journal of the American Heart Association. 6 (6), p. n/a. [Online]. 
  
Back to record